The Current Ratio as of November 2024 (TTM) for Sino Biopharmaceutical Limited (SBHMY) is 1.15

According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.15. This represents a change of 4.36% compared to the average of 1.10 of the last 4 quarters.

Sino Biopharmaceutical Limited (SBHMY) Historical Current Ratio (quarterly & annually)

How has SBHMY Current Ratio performed in the past?

The mean historical Current Ratio of Sino Biopharmaceutical Limited over the last ten years is 1.95. The current 1.15 Current Ratio has changed 5.78% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's Current Ratio was at its highest in in the March 2020 quarter at 3.36. The Current Ratio was at its lowest in in the March 2023 quarter at 1.00.

Sino Biopharmaceutical Limited (SBHMY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sino Biopharmaceutical Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sino Biopharmaceutical Limited (SBHMY) Average Current Ratio

How has SBHMY Current Ratio performed in the past?

The current Current Ratio of Sino Biopharmaceutical Limited (SBHMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sino Biopharmaceutical Limited (SBHMY) Current Ratio vs. Peers

How is SBHMY’s Current Ratio compared to its peers?

Sino Biopharmaceutical Limited’s Current Ratio is greater than Institute of Biomedical Research Corp. (0), greater than Defence Therapeutics Inc. (0.05), less than Aileron Therapeutics, Inc. (4.69), less than Enlivex Therapeutics Ltd. (10.06), less than Protagenic Therapeutics, Inc. (2.03), greater than ZIVO Bioscience, Inc. (0.17), less than Cyteir Therapeutics, Inc. (21.89), less than Eledon Pharmaceuticals, Inc. (14.48), less than Opthea Limited (2.94), less than Centessa Pharmaceuticals plc (13.29), less than Nuvalent, Inc. (17.44), less than Tarsus Pharmaceuticals, Inc. (7.03), less than Genfit S.A. (3.74), less than Anebulo Pharmaceuticals, Inc. (13.46), less than Tempest Therapeutics, Inc. (2.17), less than RenovoRx, Inc. (4.39), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Acurx Pharmaceuticals, Inc. (2.09), less than Fennec Pharmaceuticals Inc. (8.02), less than XOMA Corporation (8.71), less than Kezar Life Sciences, Inc. (9.58), less than Longboard Pharmaceuticals, Inc. (20.95), less than Entrada Therapeutics, Inc. (5.70),

Build a custom stock screener for Sino Biopharmaceutical Limited (SBHMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sino Biopharmaceutical Limited (SBHMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.